CVE-2020-10627

Severity: high (CVSS 8.1 v3.1)
Exploited in the wild: not listed in CISA KEV
EPSS: 0.5% probability of exploitation in the next 30 days
Public exploit or detection template: none known
Published: 2021-12-01 · updated 2026-06-17
Weakness: CWE-284

Description

Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Affected products

Insulet Omnipod Insulin Management System: all versions

References

https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01
https://www.myomnipod.com/security-bulletins
https://us-cert.cisa.gov/ics/advisories/icsma-20-079-01
https://www.myomnipod.com/security-bulletins

Get alerted when CVE-2020-10627 or the next vulnerability affects your stack